Bhutan's medicine, mapped to molecules.
BBCRI turns Bhutan's medicinal plants and Sowa Rigpa knowledge into AI-prioritised drug leads and evidence-backed products, for pharma and nutraceutical partners, researchers and health-conscious consumers.
Bhutan Biotech Centre for Research and Innovation.
An early-stage biotech company in Thimphu, connecting Bhutan's medicinal heritage with modern science.
BBCRI is building Sowa-Omics™, a research platform that brings together Sowa Rigpa, Bhutanese medicinal plants, omics data and AI. The aim is to find promising therapeutic leads and test them properly.
We start from what people already use. We digitise traditional formulas, trace each ingredient to its compounds and use computational tools to link those compounds to biological targets. The strongest candidates go forward to laboratory validation with research partners.
We are a small founding team with a working prototype. Our job now is to build the data, the partnerships and the lab capacity to take this from prototype to evidence.
- Based in: Thimphu, Bhutan
- Founder: Ramesh Bahadur Subba
- Platform: Sowa-Omics™
- Focus: AI-enabled drug discovery, natural products and preventive wellness
- Stage: Prototype platform, founding team
- GMC: Registering in Gelephu Mindfulness City
Sowa-Omics™: from raw biology to a tested lead, one stage at a time.
Traditional knowledge points us to promising plants and formulas. Omics and computation tell us why they might work. The lab tells us whether they do.
- Biological data: Specimens, genomes and metabolite profiles from Bhutanese flora.
- Systems understanding: Network pharmacology across pathways and formulas.
- Target discovery: Biomarkers and disease targets ranked by evidence.
- Molecule discovery: Docking and AI screening of natural-product candidates.
- Validation: ADMET prediction, then wet-lab assays with partners.
- Therapeutic development: Standardised extracts and lead compounds.
- Preventive wellness: Evidence-based products rooted in traditional practice.
Four ways Sowa-Omics™ creates revenue.
Capital-light by design: services earn early, while partnerships and products build long-term value.
- Platform: AI tools: digitised formulas, compound–target maps, docking and ADMET prediction.
- Research services: Contract work in network pharmacology and in-silico screening, built on the same platform.
- Evidence-backed products: Standardised, scientifically validated formulations from Himalayan botanicals, sold under our own brand or licensed to partners.
- Discovery partnerships: Co-develop natural-product leads with industry partners through research fees, milestone payments and royalties.
Our pipeline.
Early-stage and stated plainly: each programme shows where it really is today.
- AI-enabled drug discovery: Use integrated omics and traditional-use evidence to prioritise natural-product leads, then test them with partner laboratories.
- Natural products and medicinal plants: Characterise Bhutanese medicinal species chemically and genetically, with sustainable sourcing and cultivation in mind.
- Preventive wellness: Develop evidence-backed wellness products that respect Sowa Rigpa principles and meet modern quality standards.
- Therapeutic lead development: Carry the strongest natural-product candidates from Sowa-Omics™ into early preclinical studies with partner laboratories: confirming how they act, how potent they are and whether they are safe, starting with chronic conditions where Sowa Rigpa formulas have a long history of use.
The team.
- Ramesh Bahadur Subba, Founder. Biotechnologist based in Thimphu, building BBCRI and the Sowa-Omics™ platform. B.Sc. in Biochemistry, Genetics & Biotechnology, Jain University. Patent holder for a millet-based face-wash formulation and method. Trained in phytochemistry, computer-aided drug design and systems-biology drug discovery.
- Phub Zam, Chief Scientist. Leads BBCRI's scientific direction, from study design to validation of Sowa-Omics™ leads. Senior Laboratory Officer at the Royal Centre for Disease Control for over five years, with strong hands-on clinical laboratory experience. One of the focal persons for the National Drinking Water Quality Surveillance, and a core member of the national testing team during the COVID-19 pandemic.
- Yeshey Dema, Chief Finance Officer. Leads BBCRI's finance, fundraising and financial planning as the company moves from prototype to revenue.
Updates
- Oct 2026: BBCRI website goes live. Our first public site introduces the Sowa-Omics™ platform and what we are building.
- 2026: Sowa-Omics™ prototype running. The ingredient-to-pathway modules are working in an early web prototype.
Start a conversation.
Investors, partners and customers: tell us what you have in mind. We reply to every message.
Email ramesh@bbcri.online · Phone +975 77476075 · Thimphu, Bhutan
LinkedIn · Instagram · Facebook
This site works best with JavaScript turned on.